Ultimately, there is an imbalance of osteoclast homeostasis in favor of RANK-L and to the detriment of OPG and INFγ, resulting in osteoclast activation, bone resorption and myeloma cell survival [56]. Here, TNFRSF11B is linked to plasma cell myeloma.